Fresh analysis reveals that individuals who come off blockbuster GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who end conventional lifestyle programs.
Research printed in a leading health publication demonstrates that while overweight people frequently drop a large proportion of their total mass while on the medication, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"People purchasing such medications should be aware of the potential of rapid rebound weight gain when the medication is stopped," warns expert Dr. Susan Jebb.
Such speed of recovery implies a reversion to pre-treatment mass within about one and a half years.
Analyzing Therapies
The research, which examined dozens of studies involving over 9,000 of patients, contrasted the effects of these new drugs with older methods.
The team note that people who shed pounds through lifestyle changes alone typically see a more gradual creep back—approximately 100 grams monthly—post-intervention.
Explaining the Fast Rebound
Experts suggest the mechanism of the injections explains the amplified weight return.
The injections copy a natural hormone called glucagon-like peptide-1, which moderates hunger.
"Long-term administration of GLP-1 concentrations far above than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication means appetite is unsuppressed, making binge eating far more likely."
A Chronic Disease?
The NHS suggest the injections for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians contend that, given the likelihood of relapse, the therapy should be considered long-term.
This opinion is echoed by pharmaceutical companies, who state that the findings "underscore the chronic nature of excess weight," akin to managing diseases like hypertension.
Patient Accounts
People who have discontinued the medication describe a sudden return of cravings.
"I experienced a switch activating and you become extremely hungry," described a patient.
This difficulty is worsened if patients have not adopted permanent lifestyle or habit changes during therapy.
Significant Adoption
Recent estimates show that millions of people in the UK have used weight-loss jabs in the past year, with demand being substantial.
- Adoption is greater among women than men.
- The 40s and 50s age group shows the highest level of interest.
- Many access the medications through private prescriptions rather than public health services.
Finally, experts stress that while these medications are powerful tools for weight loss, they are not a standalone fix and maintained weight loss hinges on ongoing behavioural management.